on May 13, 2002
Published online before print May 13, 2002, doi: 10.1161/01.CIR.0000018949.39445.40
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 14, 2002
From the Center for Research in Cardiovascular Interventions, Stanford University Medical Center, Stanford, Calif (Y.M., T.L., Y.H., P.G.Y., P.J.F.); Washington Hospital Center, Washington, DC (R.W.); Cardiovascular Research Foundation, New York, NY (A.J.L., G.S.M.); and Highlands Consulting Inc, San Jose, Calif (H.N.B.). * To whom correspondence should be addressed. E-mail: ivus{at}crci.stanford.edu.
Background—Re-stenting of in-stent restenosis (ISR) improves acute angiographic results. Methods and Results—Volumetric intravascular ultrasound analysis was performed in 70 ISR lesions that received either placebo (n=36) or 192Ir radiation (n=34). ISR lesions treated by re-stenting were divided into 3 groups: old stent not re-stented (A), old/new stent overlap (B), and new stent only (C). ISR lesions treated without re-stenting were categorized as D. In placebo patients, postintervention lumen volume index (LVI) was significantly greater in re-stented segments B and C than in non--re-stented segment A (P<0.05).At follow-up, however, LVI was similar in all 4 segments secondary to the increased intimal hyperplasia (IH) reaccumulation within the re-stented segments. In patients treated with 192Ir radiation, LVI was maintained from baseline to follow-up only in non--re-stented segments A and D. Conversely, there was a significant decrease in LVI in re-stented segments B and C (P<0.05). Qualitatively, 79% of patients in the irradiated group had stent struts with undetectable neointimal versus only 27% in the placebo group (P<0.001). Coefficient of variation of IH reaccumulation was greater in re-stented segments of 192Ir patients (B=57.3% and C=58.9%) than in re-stented segments in placebo patients (B=27.3% and C 26.8%) and non--re-stented segments in irradiated patients. Conclusions—Additional lumen gain from re-stenting ISR lesions is counteracted by exaggerated neointimal proliferation in placebo patients. Maximum effectiveness and safety of radiation can be achieved for ISR lesions when treated without re-stenting. Thus, regardless of supplementary intravascular brachytherapy, repeat stenting strategies provided little long-term advantage.
Revised on April 10, 2002
Accepted on April 10, 2002
Late Vascular Response to Repeat Stenting for
In-Stent Restenosis With and Without Radiation. An Intravascular Ultrasound Volumetric
Analysis
Yoshihiro Morino MD,
Key words: restenosis • radioisotopes • stents • coronary disease